Considering that not only H2DCFDA staining but also MitoSOX staining showed a high ROS level in DSF-treated EpCAM+ HCC cells, DSF might increases mitochondrial ROS production rather than impairs the scavenging of ROS. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.